Health Canada inspection
GlaxoSmithKline Inc.: Health Canada inspection of Jun 23, 2021
Health Canada · GMP · rating C
Key facts
| Establishment | GlaxoSmithKline Inc. |
|---|---|
| City | Mississauga |
| Province | Ontario |
| Country | Canada |
| Program | GMP |
| Start date | Jun 14, 2021 |
| End date | Jun 23, 2021 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 100630 |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- Yes Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.